Serum antimicrobial peptides in patients with familial Mediterranean fever

Abdurrahman Tufan1, Rıdvan Mercan1, Ozge Tugce Pasaoglu2

  • 1Gazi University, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey.

Peptides
|April 22, 2014
PubMed

Insights

Antimicrobial peptides (AMPs), including cathelicidin (LL37) and defensins, are elevated in Familial Mediterranean Fever (FMF) patients. These immune components may play a role in FMF pathogenesis, even after treatment.

Area of Science:

  • Immunology
  • Genetics
  • Rheumatology

Background:

  • Familial Mediterranean Fever (FMF) involves recurrent inflammation of serosal and synovial membranes.
  • While genetic, FMF attacks can be triggered by environmental factors like infections.
  • Antimicrobial peptides (AMPs) are key innate immunity components with immunomodulatory roles in inflammation.

Purpose of the Study:

  • To investigate serum concentrations of specific antimicrobial peptides (AMPs) in newly diagnosed Familial Mediterranean Fever (FMF) patients.
  • To compare AMP levels in FMF patients with healthy controls and assess changes during attacks and after colchicine therapy.

Main Methods:

  • Serum samples collected from 23 newly diagnosed FMF patients at baseline, during attacks, and 6 months post-colchicine treatment.
  • Serum samples from 24 healthy individuals served as controls.
  • Concentrations of cathelicidin (LL37), alpha-1, beta-1, and beta-2 defensins measured using ELISA.

Main Results:

  • Serum AMP levels did not significantly change during FMF attacks or correlate with acute phase reactants.
  • FMF patients exhibited significantly higher serum concentrations of LL37 and defensins compared to healthy controls.
  • Elevated AMP levels persisted in FMF patients even 6 months after initiating colchicine therapy.

Conclusions:

  • Serum LL37 and defensins are markedly elevated in FMF patients, suggesting a potential role in the disease's pathogenesis.
  • AMPs may be involved in the underlying inflammatory processes of FMF, independent of acute attack status or standard treatment.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.4K